{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T16:46:46Z","timestamp":1772038006395,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003669","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["2021E6300200"],"award-info":[{"award-number":["2021E6300200"]}],"id":[{"id":"10.13039\/501100003669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018688","name":"Korea Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018688","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.msard.2023.104957","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T15:55:38Z","timestamp":1693583738000},"page":"104957","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Serum neurofilament and glial fibrillary acidic protein in idiopathic and seropositive transverse myelitis"],"prefix":"10.1016","volume":"79","author":[{"given":"Hye Lim","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Myoung","family":"Seok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Hak","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-Hong","family":"Min","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seol-Hee","family":"Baek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunhee","family":"Sohn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhyeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa-Yoon","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon-Ho","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ha Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joong-Yang","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeeyoung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su-Hyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Jo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2023.104957_bib0001","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1046\/j.1468-1331.1998.510035.x","article-title":"Magnetic resonance imaging findings in 22 cases of myelitis: comparison between patients with and without multiple sclerosis","volume":"5","author":"Bakshi","year":"1998","journal-title":"Eur. J. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2023.104957_bib0002","doi-asserted-by":"crossref","first-page":"A395","DOI":"10.1016\/j.autrev.2009.12.007","article-title":"The epidemiology of transverse myelitis","volume":"9","author":"Bhat","year":"2010","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.msard.2023.104957_bib0003","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1093\/brain\/awab241","article-title":"The potential of serum neurofilament as biomarker for multiple sclerosis","volume":"144","author":"Bittner","year":"2021","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.msard.2023.104957_bib0004","first-page":"1","article-title":"Neurofilament light chain in demyelinating conditions of the central nervous system: a promising biomarker","volume":"8","author":"Bozzetti","year":"2021","journal-title":"Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2023.104957_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.neulet.2014.01.055","article-title":"Role of GFAP in CNS injuries","volume":"565","author":"Brenner","year":"2014","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.msard.2023.104957_bib0006","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1191\/135248506ms1260oa","article-title":"Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases","volume":"12","author":"Bruna","year":"2006","journal-title":"Mult. Scler. J."},{"issue":"4","key":"10.1016\/j.msard.2023.104957_bib0007","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3988\/jcn.2022.18.4.453","article-title":"Disease course and outcomes in patients with the limited form of neuromyelitis optica spectrum disorders and negative AQP4-IgG serology at disease onset: a prospective cohort study","volume":"18","author":"Chen","year":"2022","journal-title":"J. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2023.104957_bib0008","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1212\/CON.0000000000000900","article-title":"Myelitis and other autoimmune myelopathies","volume":"27","author":"Chiriboga","year":"2021","journal-title":"Contin. Lifelong Learn. Neurol."},{"issue":"5","key":"10.1016\/j.msard.2023.104957_bib0009","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-0404.1990.tb00990.x","article-title":"Clinical course and long-term prognosis of acute transverse myelopathy","volume":"81","author":"Christensen","year":"1990","journal-title":"Acta Neurol. Scand."},{"issue":"1","key":"10.1016\/j.msard.2023.104957_bib0010","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s13760-021-01712-3","article-title":"Comparative study of AQP4-NMOSD, MOGAD and seronegative NMOSD: a single-center Belgian cohort","volume":"122","author":"Dauby","year":"2022","journal-title":"Acta Neurol. Belg."},{"issue":"6","key":"10.1016\/j.msard.2023.104957_bib0011","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/08830738030180060601","article-title":"Acute transverse myelitis in children: clinical course and prognostic factors","volume":"18","author":"Defresne","year":"2003","journal-title":"J. Child Neurol."},{"issue":"4","key":"10.1016\/j.msard.2023.104957_bib0012","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.0000000000001179","article-title":"Acute idiopathic transverse myelitis in children: early predictors of relapse and disability","volume":"84","author":"Deiva","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104957_bib0013","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1590\/0004-282x20190060","article-title":"Neurofilament light chain in the assessment of patients with multiple sclerosis","volume":"77","author":"Domingues","year":"2019","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.msard.2023.104957_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2019.101413","article-title":"Long-term outcome and prognosis in patients with neuromyelitis optica spectrum disorder from Serbia","volume":"36","author":"Drulovic","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.msard.2023.104957_bib0015","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1212\/WNL.59.4.499","article-title":"Proposed diagnostic criteria and nosology of acute transverse myelitis","volume":"59","year":"2002","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.msard.2023.104957_bib0016","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1177\/1352458514551454","article-title":"Idiopathic aquaporin-4 antibody negative longitudinally extensive transverse myelitis","volume":"21","author":"Hyun","year":"2015","journal-title":"Mult. Scler. J."},{"issue":"2","key":"10.1016\/j.msard.2023.104957_bib0017","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3988\/jcn.2022.18.2.152","article-title":"An update on the laboratory diagnosis of neuromyelitis optica spectrum disorders","volume":"18","author":"Jeyalatha","year":"2022","journal-title":"J. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2023.104957_bib0018","doi-asserted-by":"crossref","first-page":"280","DOI":"10.3988\/jcn.2022.18.3.280","article-title":"Clinical and radiological features of myelin oligodendrocyte glycoprotein-associated myelitis in adults","volume":"18","author":"Kim","year":"2022","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.msard.2023.104957_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2019.576999","article-title":"Cytokines and biological markers in autoimmune GFAP astrocytopathy: the potential role for pathogenesis and therapeutic implications","volume":"334","author":"Kimura","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.msard.2023.104957_bib0020","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/acn3.51070","article-title":"Clinical implication of serum biomarkers and patient age in inflammatory demyelinating diseases","volume":"7","author":"Lee","year":"2020","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"2","key":"10.1016\/j.msard.2023.104957_bib0021","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3988\/jcn.2022.18.2.207","article-title":"Results of a survey on diagnostic procedures and treatment choices for neuromyelitis optica spectrum disorder in Korea: beyond the context of current clinical guidelines","volume":"18","author":"Lee","year":"2022","journal-title":"J. Clin. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2023.104957_bib0022","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1136\/jnnp.64.3.402","article-title":"Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosis","volume":"64","author":"Lycke","year":"1998","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"4","key":"10.1016\/j.msard.2023.104957_bib0023","article-title":"Serum neurofilament light chain in NMOSD and related disorders: comparison according to aquaporin-4 and myelin oligodendrocyte glycoprotein antibodies status","volume":"3","author":"Mariotto","year":"2017","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"22","key":"10.1016\/j.msard.2023.104957_bib0024","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1212\/WNL.0000000000004683","article-title":"Monitoring disease activity in multiple sclerosis using serum neurofilament light protein","volume":"89","author":"Novakova","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104957_bib0025","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.msard.2019.02.009","article-title":"Increased cerebrospinal fluid neurofilament light chain in central nervous system inflammatory demyelinating disease","volume":"30","author":"Peng","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2023.104957_bib0026","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1177\/13524585211039104","article-title":"Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based study","volume":"28","author":"Rosenstein","year":"2022","journal-title":"Mult. Scler. J."},{"issue":"1","key":"10.1016\/j.msard.2023.104957_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-021-02138-7","article-title":"Serum GFAP and NfL as disease severity and prognostic biomarkers in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder","volume":"18","author":"Schindler","year":"2021","journal-title":"J. Neuroinflammation"},{"issue":"5","key":"10.1016\/j.msard.2023.104957_bib0028","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1177\/1352458512443092","article-title":"Neurofilaments as biomarkers in multiple sclerosis","volume":"18","author":"Teunissen","year":"2012","journal-title":"Mult. Scler. J."},{"issue":"1","key":"10.1016\/j.msard.2023.104957_bib0029","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-67504-6","article-title":"Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis","volume":"10","author":"Thebault","year":"2020","journal-title":"Sci. Rep."},{"issue":"13","key":"10.1016\/j.msard.2023.104957_bib0030","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1212\/WNL.0000000000008160","article-title":"Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD","volume":"93","author":"Watanabe","year":"2019","journal-title":"Neurology"},{"issue":"88","key":"10.1016\/j.msard.2023.104957_bib0031","first-page":"167","article-title":"Transverse myelitis\u2014A review of the presentation, diagnosis, and initial management","volume":"16","author":"West","year":"2013","journal-title":"Discov. Med."},{"issue":"2","key":"10.1016\/j.msard.2023.104957_bib0032","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1212\/WNL.0000000000004796","article-title":"Evaluation of idiopathic transverse myelitis revealing specific myelopathy diagnoses","volume":"90","author":"Zalewski","year":"2018","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2023.104957_bib0033","doi-asserted-by":"crossref","DOI":"10.1177\/17562864211054952","article-title":"Longitudinal treatment responsiveness on plasma neurofilament light chain and glial fibrillary acidic protein levels in neuromyelitis optica spectrum disorder","volume":"14","author":"Zhang","year":"2021","journal-title":"Ther. Adv. Neurol. Disord."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823004583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034823004583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T16:03:26Z","timestamp":1727453006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034823004583"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":33,"alternative-id":["S2211034823004583"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2023.104957","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum neurofilament and glial fibrillary acidic protein in idiopathic and seropositive transverse myelitis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2023.104957","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104957"}}